Qinecsa CEO, Adam Sherlock, has been featured in Pharma Times’ latest issue, where he discusses how embracing next-generation, AI-driven process automation supports pharma with ongoing drug safety monitoring. He highlights, however, that AI should never replace human expertise – together efficiency improves sharply, with exposure and training helping to continuously refine accuracy.
